Sofinnova Investments’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.7M Buy
1,131,786
+246,665
+28% +$8.28M 1.43% 24
2025
Q4
$30.6M Sell
885,121
-37,574
-4% -$1.2M 1.32% 25
2025
Q3
$25.1M Sell
922,695
-1,225,100
-57% -$29.6M 1.37% 24
2025
Q2
$45.1M Sell
2,147,795
-474,397
-18% -$9.1M 2.76% 11
2025
Q1
$43M Buy
2,622,192
+1,553,102
+145% +$33.1M 2.81% 11
2024
Q4
$27.5M Sell
1,069,090
-680,365
-39% -$19.3M 2% 16
2024
Q3
$55.4M Buy
1,749,455
+597,927
+52% +$22.7M 4.4% 5
2024
Q2
$40.4M Buy
1,151,528
+369,932
+47% +$14.6M 2.1% 16
2024
Q1
$34.3M Sell
781,596
-677,285
-46% -$29.1M 1.91% 19
2023
Q4
$51.9M Buy
1,458,881
+421,694
+41% +$12.6M 2.9% 9
2023
Q3
$28M Buy
1,037,187
+372,441
+56% +$9.44M 1.77% 20
2023
Q2
$15.6M Buy
664,746
+211,597
+47% +$4.35M 1.02% 23
2023
Q1
$6.22M Sell
453,149
-21,381
-5% -$356K 0.4% 38
2022
Q4
$8.62M Sell
474,530
-180,226
-28% -$3.03M 0.51% 31
2022
Q3
$9.77M Buy
+654,756
New +$8.5M 0.57% 33

Other funds holding IDYA

Sofinnova Investments's IDYA Position: Q1 2026 in Review

Sofinnova Investments increased its IDEAYA Biosciences (IDYA) stake by 28% in Q1 2026, buying an estimated $8.28M and bringing the position to 1,131,786 shares worth $37.7M. The position accounts for 1.43% of the portfolio, ranked #24.

Sofinnova Investments first reported a position in IDYA in Q3 2022 and has held it in 15 quarters since. The position peaked at $55.4M in Q3 2024. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Sofinnova Investments held 1,131,786 shares of IDEAYA Biosciences worth $37.7M as of Q1 2026.
  • Sofinnova Investments bought 246,665 IDEAYA Biosciences shares in Q1 2026, an estimated $8.28M.
  • IDEAYA Biosciences made up 1.43% of Sofinnova Investments's portfolio in Q1 2026, its #24 holding.
  • Sofinnova Investments first reported a position in IDEAYA Biosciences in Q3 2022 and has held it in 15 quarters since.
  • Sofinnova Investments's IDEAYA Biosciences position peaked at $55.4M in Q3 2024.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Sofinnova Investments's 13F filing for Q1 2026, filed 15 May 2026.